Resources

  1. National Guideline Clearinghouse (NGC). Guideline summary: Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2016 May 10. [cited 2017 Jun 29]. Available: https://www.guideline.gov
  2. Becker, W. (2015). Acute migraine treatment in adults. Headache, 55:778-793 doi: 10.1111/head.12550 https://www.ncbi.nlm.nih.gov/pubmed/25877672
  3. Mosadeghi-Nik, M., Askari, M. Fatehi, F. (2016).  Mobile health (mHealth) for headache disorders: A review of the evidence base. Journal of Telemedicine and Telecare, 22 (8), 472-477. doi: 10.1177/1357633X16673275 https://www.ncbi.nlm.nih.gov/pubmed/27799450